Development
An AI-designed antibody clears early safety and draws a $100M round
Claim
Absci jumped 24% on early safety data for its AI-designed hair-loss antibody, drawing a $100 million round led by Eli Lilly that also bets on an endometriosis treatment.
Reported metric: $100M round
Reporting date: (not necessarily the event date)
Sources
Attribution and reporting linked by this record; links do not imply independent verification.
- Welcome to June 26, 2026 (theinnermostloop.substack.com)
Cite or correct this record
Suggest a correction — opens a GitHub draft for you to review and submit.